Acadian Asset Management LLC Alkermes Plc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 18,870 shares of ALKS stock, worth $561,382. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,870

Previous 13,925 35.51%

Holding current value

$561,382

Previous $335,000 57.31%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$23.01 - $28.55 $113,784 - $141,179	4,945 Added 35.51%	18,870 $527,000
Q2 2024 Aug 06, 2024	SELL	$23.21 - $27.24 $275,177 - $322,957	-11,856 Reduced 45.99%	13,925 $335,000
Q1 2024 May 10, 2024	BUY	$26.4 - $32.56 $281,714 - $347,447	10,671 Added 70.62%	25,781 $697,000
Q4 2023 Feb 13, 2024	SELL	$23.37 - $28.68 $8.08 Million - $9.92 Million	-345,783 Reduced 95.81%	15,110 $418,000
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $9.25 Million - $10.9 Million	340,299 Added 1652.42%	360,893 $10.1 Million
Q2 2023 Aug 07, 2023	BUY	$28.34 - $33.63 $583,633 - $692,576	20,594 New	20,594 $644,000
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $6.64 Million - $7.94 Million	-302,578 Reduced 67.89%	143,106 $3.73 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $8.03 Million - $11.6 Million	364,804 Added 451.04%	445,684 $9.94 Million
Q2 2022 Aug 09, 2022	BUY	$26.4 - $30.54 $1.56 Million - $1.8 Million	58,935 Added 268.56%	80,880 $2.41 Million
Q1 2022 May 12, 2022	BUY	$23.07 - $27.99 $439,714 - $533,489	19,060 Added 660.66%	21,945 $576,000
Q4 2021 Feb 10, 2022	SELL	$21.47 - $32.08 $4.78 Million - $7.14 Million	-222,634 Reduced 98.72%	2,885 $67,000
Q3 2021 Nov 12, 2021	SELL	$23.37 - $32.13 $1.63 Million - $2.24 Million	-69,632 Reduced 23.59%	225,519 $6.95 Million
Q2 2021 Aug 11, 2021	SELL	$18.78 - $25.15 $2.44 Million - $3.26 Million	-129,786 Reduced 30.54%	295,151 $7.24 Million
Q1 2021 May 11, 2021	SELL	$18.21 - $23.2 $10.5 Million - $13.4 Million	-575,928 Reduced 57.54%	424,937 $7.94 Million
Q4 2020 Feb 11, 2021	BUY	$15.39 - $22.1 $3.82 Million - $5.49 Million	248,257 Added 32.99%	1,000,865 $20 Million
Q3 2020 Nov 09, 2020	SELL	$16.16 - $20.66 $3.44 Million - $4.4 Million	-212,821 Reduced 22.04%	752,608 $12.5 Million
Q2 2020 Aug 12, 2020	BUY	$13.31 - $19.41 $11.2 Million - $16.3 Million	838,628 Added 661.37%	965,429 $18.7 Million
Q1 2020 May 11, 2020	BUY	$13.06 - $21.24 $222,725 - $362,226	17,054 Added 15.54%	126,801 $1.83 Million
Q4 2019 Feb 06, 2020	BUY	$17.29 - $21.74 $1.71 Million - $2.15 Million	99,103 Added 931.07%	109,747 $2.24 Million
Q3 2019 Nov 07, 2019	BUY	$19.51 - $24.28 $66,314 - $82,527	3,399 Added 46.92%	10,644 $207,000
Q2 2019 Aug 08, 2019	BUY	$21.47 - $37.33 $155,550 - $270,455	7,245 New	7,245 $163,000
Q3 2018 Oct 30, 2018	SELL	$38.6 - $46.12 $6,755 - $8,071	-175 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$40.56 - $51.36 $7,098 - $8,988	175 New	175 $7,000

Others Institutions Holding ALKS

# of Institutions

364

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.89B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Alkermes Plc. Transaction History